DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ce57f3/overactive_bladder) has announced the addition of Global Markets Direct's new report "Overactive Bladder - Pipeline Review, Q4 2010" to their offering.
Overactive Bladder Pipeline Review, Q4 2010, provides an overview of the Overactive Bladder therapeutic pipeline. This report provides information on the therapeutic development for Overactive Bladder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Overactive Bladder. Overactive Bladder-Pipeline Review 2010, Q4 2010 is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources
Scope
- A snapshot of the global therapeutic scenario for Overactive Bladder.
- A review of the Overactive Bladder products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Overactive Bladder pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
- List of Tables
- List of Figures
- Introduction
- Global Markets Direct Report Coverage
- Overactive Bladder Overview
- Therapeutics Development
- An Overview of Pipeline Products for Overactive Bladder
- Overactive Bladder Therapeutics under Development by Companies
- Overactive Bladder Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Companies Involved in Overactive Bladder Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/ce57f3/overactive_bladder